Pacific Edge sees $100m revenue from US in five years

Preparing reagents for the Cxbladder test

Dunedin-based bladder cancer detection test inventor Pacific Edge believes it could be turning over $100 million a year in the United States within five years, following the registration of its own diagnostic laboratory in Pennsylvania.

The closely held, NZX-listed company announced the registration milestone today, saying its Hershey, Pennsylvania, laboratory had received CLIA (Clinical Labour Improvement Amendment) registration, allowing it to start using its patented Cxbladder test to diagnose bladder tumours.

The company has published research showing the non-invasive Cxbladder procedure is more successful than current more costly and invasive methods such as cystoscopy.

CLIA registration is essential for operations in the US, which Pacific Edge has elected to establish as a wholly owned subsidiary rather than cede most of the potential revenue from the business to third-party diagnostic laboratories.

The go-it-alone stance also requires the company to establish sales and marketing presence in the US, a process it has already begun and will ramp up in coming months. As well as targeting returned armed services organisations, Pacific Edge is dealing with so-called Large Urology Groups (LUGs), which account for about 15 percent of the total US urology market.

The Pennsylvania site adjoins a research hospital and was chosen for its proximity to the so-called BOSNYWash cities of the north-eastern United States and because the state government paid for "the lion's share" of the lab fit-out, said New Zealand chief executive David Darling.

A US CEO was also appointed in April last year to lead development of the market.

Ten years to achieve

The CLIA registration and consequent US commercial sales potential comes after 10 years and some $28 million of capital investment on Cxbladder and a range of other diagnostic tests to be rolled out in the future.

Some 60 percent of the register is held by about 20 high-net worth individuals, including the family of investor Peter Masfen, Warehouse founder Sir Stephen Tindall and Dunedin sharebroker Eion Edgar.

The investment to date was equivalent to one or two years' typical cash burn in the US for a medical start-up, Mr Darling says.

"The capability to build this business opportunity in the US off the back of the New Zealand business has been a significant factor in enabling this market channel to be delivered quickly and very cost-effectively."

The test is already available in Australia and New Zealand and will be launched soon in Spain, which has the highest global incidence of bladder cancer.

Pacific Edge intends to have its Dunedin laboratory CLIA-registered shortly, to take overflow work. It has already been used in the registration phase to test American urine samples, with courier arrangements between Dunedin and Pennsylvania still allowing the company to keep its promise of diagnosis within three to five days.

Pacific Edge shares were off 4 percent in mid-afternoon NZX trading, at 73 cents, but have still gained 15.2 percent in the last week and are up 85.4 percent over the last three months.

(BusinessDesk)

This article is tagged with the following keywords. Find out more about My Tags

Post Comment

7 Comments & Questions

Commenter icon key: Subscriber Verified

Yeah right

Pacific Edge have been 'gunna" do a lot of things for the past 5 years and achieved little other than raise cash to fund the fat machine.

Buyer beware

Reply
Share

What a lot of rubbish -- they were most helpful in confirming I did not have bladder cancer

Reply
Share

Guess you were saying the same thing about Diligent?

Reply
Share

Ignorance is bliss, I guess.

Clinically proving a revolutionary cancer diagnostic test, building a lab in a faraway country and designing a plan to commercialise the test must be something you expect to only take six months.

Some people shouldn't own shares. You are one of them. Find yourself a nice Bonus Bond and maybe you can be a winner at least once in your life.

Reply
Share

OK, so if you have a bladder cancer scare you will be taking the old fashioned test of a 30cm piece of wire up inserted up your "johnson" rather than the Pacific Edge peeing in a cup test then? Thought not.

Reply
Share

Well done, Pacific Edge. And well done to those who supported this enterprising Dunedin-based company.

Reply
Share

All great businesses take one step at a time

Reply
Share

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

NZ Market Snapshot

Forex

Sym Price Change
USD 0.7878 -0.0004 -0.05%
AUD 0.9091 0.0005 0.06%
EUR 0.6356 -0.0003 -0.05%
GBP 0.5032 0.0001 0.02%
HKD 6.1123 -0.0013 -0.02%
JPY 92.8410 0.0020 0.00%

Commods

Commodity Price Change Time
Gold Index 1201.1 7.690 2014-11-21T00:
Oil Brent 78.6 -0.120 2014-11-21T00:
Oil Nymex 76.5 0.710 2014-11-21T00:
Silver Index 16.4 0.260 2014-11-21T00:

Indices

Symbol Open High Last %
NZX 50 5526.9 5526.9 5526.9 -0.56%
NASDAQ 4751.0 4751.6 4701.9 0.24%
DAX 9521.2 9736.1 9484.0 2.62%
DJI 17721.0 17894.8 17719.0 0.51%
FTSE 6678.9 6773.1 6678.9 1.08%
HKSE 23353.7 23508.0 23349.6 0.37%
NI225 17285.7 17381.6 17300.9 0.33%